BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang N, Tan HY, Chan YT, Guo W, Li S, Feng Y. Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient protocatechualdehyde. Oncotarget 2017;8:105848-59. [PMID: 29285297 DOI: 10.18632/oncotarget.22406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Jia L, Lin X, Guo W, Huang M, Zhao Y, Zhang Y, Li J. Salvia chinensia Benth induces autophagy in esophageal cancer cells via AMPK/ULK1 signaling pathway. Front Pharmacol 2022;13:995344. [DOI: 10.3389/fphar.2022.995344] [Reference Citation Analysis]
2 Wang K, Hu Y, Han L, Zhao S, Song C, Sun S, Lv H, Jiang N, Xv L, Zhao Z, Li M. Salvia chinensis Benth Inhibits Triple-Negative Breast Cancer Progression by Inducing the DNA Damage Pathway. Front Oncol 2022;12:882784. [DOI: 10.3389/fonc.2022.882784] [Reference Citation Analysis]
3 Yu Q, Chen Z, Liu M, Meng Y, Li X, Li B, Du J. Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology. J Ethnopharmacol 2022;297:115531. [PMID: 35840058 DOI: 10.1016/j.jep.2022.115531] [Reference Citation Analysis]
4 Fu D, Ji Q, Wang C, Yu L, Yu R. Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis. Cell Cycle 2021;:1-18. [PMID: 34720052 DOI: 10.1080/15384101.2021.1988227] [Reference Citation Analysis]
5 Tian L, Wang X, Zhang D, Wu M, Xue Z, Liu Z, Yang S, Li H, Gong G. Evaluation of the membrane damage mechanism of protocatechualdehyde against Yersinia enterocolitica and simulation of growth inhibition in pork. Food Chem 2021;363:130340. [PMID: 34144416 DOI: 10.1016/j.foodchem.2021.130340] [Reference Citation Analysis]
6 Park J, Jeong D, Song M, Kim B. Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery. Antioxidants (Basel) 2021;10:527. [PMID: 33801741 DOI: 10.3390/antiox10040527] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
7 Chen F, Zhong Z, Tan HY, Guo W, Zhang C, Cheng CS, Wang N, Ren J, Feng Y. Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR-22-3p. Clin Transl Med 2020;10:e190. [PMID: 33135336 DOI: 10.1002/ctm2.190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
8 Tuersong T, Li L, Abulaiti Z, Feng S. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer. Mol Med Rep 2019;19:4697-710. [PMID: 31059025 DOI: 10.3892/mmr.2019.10165] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
9 Kong Z, Liu R, Cheng Y. Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway. Biomed Pharmacother 2019;109:2043-53. [PMID: 30551460 DOI: 10.1016/j.biopha.2018.11.030] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 16.5] [Reference Citation Analysis]
10 Guo G, Zhou J, Yang X, Feng J, Shao Y, Jia T, Huang Q, Li Y, Zhong Y, Nagarkatti PS, Nagarkatti M. Role of MicroRNAs Induced by Chinese Herbal Medicines Against Hepatocellular Carcinoma: A Brief Review. Integr Cancer Ther 2018;17:1059-67. [PMID: 30343602 DOI: 10.1177/1534735418805564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]